Human amniotic membrane homogenate: A novel biomaterial-based strategy to impede migration and invasion of bladder cancer cells Abstract
Article Sidebar
Main Article Content
Abstract
Bladder cancer ranks among the top ten most frequently diagnosed cancers globally, with approximately 25 % of diagnosed cases presenting as initially aggressive muscle-invasive tumours, marked by poor prognosis and frequent metastasis. Human amniotic membrane (hAM) is an extraembryonic membrane with anti-inflammatory, antifibrotic and antimicrobial properties, however, despite the growing number of studies, the cellular mechanisms underpinning its anticancer activity remain poorly elucidated. In our investigation, we delved into the mechanisms by which hAM homogenate influences bladder cancer and normal urothelial cells.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors grant to the Publisher the following rights to the manuscript, including any supplemental material, and any parts, extracts or elements thereof:
- the right to reproduce and distribute the Manuscript in printed form, including print-on-demand;
- the right to produce prepublications, reprints, and special editions of the Manuscript;
- the right to translate the Manuscript into other languages;
- the right to reproduce the Manuscript using photomechanical or similar means including, but not limited to photocopy, and the right to distribute these reproductions;
- the right to reproduce and distribute the Manuscript electronically or optically on any and all data carriers or storage media – especially in machine readable/digitalized form on data carriers such as hard drive, CD-Rom, DVD, Blu-ray Disc (BD), Mini-Disk, data tape – and the right to reproduce and distribute the Article via these data carriers;
- the right to store the Manuscript in databases, including online databases, and the right of transmission of the Manuscript in all technical systems and modes;
- the right to make the Manuscript available to the public or to closed user groups on individual demand, for use on monitors or other readers (including e-books), and in printable form for the user, either via the internet, other online services, or via internal or external networks.
How to Cite
References
Park JC, Citrin DE, Agarwal PK, Apolo AB. Multimodal management of muscle-invasive bladder cancer. Curr Probl Cancer. 2014 May-Jun;38(3):80-108. https://doi.org/10.1016/j.currproblcancer.2014.06.001
Leal-Marin S, Kern T, Hofmann N, Pogozhykh O, Framme C, Börgel M, Figueiredo C, Glasmacher B, Gryshkov O. Human Amniotic Membrane: A review on tissue engineering, application, and storage. J Biomed Mater Res B Appl Biomater. 2021 Aug;109(8):1198-1215. https://doi.org/10.1002/jbm.b.34782
Janev A, Ramuta TŽ, Jerman UD, Obradović H, Kamenšek U, Čemažar M, Kreft ME. Human amniotic membrane inhibits migration and invasion of muscle-invasive bladder cancer urothelial cells by downregulating the FAK/PI3K/Akt/mTOR signalling pathway. Sci Rep. 2023 Nov 6;13(1):19227. https://doi.org/10.1038/s41598-023-46091-2.
Silini AR, Ramuta TŽ, Pires AS, Banerjee A, Dubus M, Gindraux F, Kerdjoudj H, Maciulatis J, Weidinger A, Wolbank S, Eissner G, Giebel B, Pozzobon M, Parolini O, Kreft ME. Front Bioeng Biotechnol. 2022 Oct 13;10:958669. https://doi.org/10.3389/fbioe.2022.958669.